Previous Section | Index | Home Page |
13 Jan 2010 : Column 1018Wcontinued
The agreed funding allocation to these organisations for the next three years are provided in the following table.
£ | ||||
Organisation | Activity | 2010 | 2011 | 2012 |
Rights of women and children experiencing violence and abuse | ||||
National Forum of People Living with HIV/AIDS Networks in Uganda (NAFOPHANU) | ||||
Mr. Carmichael: To ask the Secretary of State for International Development what aid his Department has provided to Uganda in each of the last five years; and what aid he expects his Department to provide to Uganda in each of the next five years. [309709]
Mr. Thomas: The Department for International Development (DFID) signed a 10-year partnership agreement with the Government of Uganda (GoU) in November 2007. Under this partnership agreement the UK Government pledged £700 million worth of development support to the GoU over the period 2007-17.
DFID aid to Uganda in each of the last five years was as follows:
£ million | |
Indicative aid allocations to Uganda over the next five years are as follows:
£ million | |
Aid provided by DFID to Uganda is conditional on progress in reducing poverty, strengthening financial management and respecting human rights and international obligations.
Dr. Iddon: To ask the Secretary of State for Health how many lower limb (a) revascularisation and (b) angioplasty procedures were carried out in each strategic health authority in the NHS in each of the last five years. [309972]
Ann Keen: We are unable to provide data for revascularisation. There are no specific codes for 'revascularisation of lower limb' in the national classification (OPCS-4) and cannot thus be separately identified.
Tables providing the number of finished consultant episodes (FCEs) with a primary or secondary procedure of angioplasty of the lower limb, by strategic health authority (SHA) of treatment for the years 2004-05 to 2008-09 have been placed in the Library.
In 2006-07 there was a SHA configuration change, where 28 SHAs merged into 10. For this reason, data for 2006-07 to 2008-09 is based on the new configuration and the data prior to this is based on the old configuration.
It should be noted that the number of FCEs does not represent the number of patients as a patient may have more than one episode within a year.
Reference should be made to the footnotes and clinical codes when interpreting the data.
Grant Shapps: To ask the Secretary of State for Health what estimate he has made of his Department's expenditure on (a) television, (b) radio, (c) print and (d) online advertising in (i) 2009-10 and (ii) 2010-11. [309932]
Phil Hope: The Department's estimated expenditure on advertising for the 2009-10 financial year is given in the following table. These are provisional figures because advertising media allocations for some campaigns are still subject to change.
Channel | Estimated expenditure (£) |
The figures do not include recruitment or classified advertising costs. Advertising spend is defined as covering only media spend (inclusive of agency commissions but excluding production costs, Central Office of Information commission and VAT). All figures exclude advertising rebates and audit adjustments and therefore may differ from Central Office of Information official turnover figures.
A total budget figure for the 2010-11 financial year cannot be provided at this stage as detailed planning for some campaigns is under way and advertising media allocations have not yet been finalised.
Mr. Philip Hammond: To ask the Secretary of State for Health how many days sickness absence were taken by staff in his Department and its agencies in each of the last 12 months for which figures are available; and what the cost to his Department was of such absence. [305555]
Phil Hope: The Department gives managing sickness absence the importance it deserves. Our policy 'Managing Sickness Absence-promoting attendance at work' promotes a positive approach to managing and responding to sickness absence.
Human Resources routinely make contact with line managers and members of staff at agreed absence trigger points, advising on the policy and support available to maximise attendance and support health and well-being at work. This can include occupational health referrals, return to work interviews, making use of the employee assistance programme, and consideration of reasonable adjustments to the role or physical environment.
Human Resources provide continued support to managers and members of staff in maintaining acceptable attendance levels and advising on process for formal action where acceptable attendance levels cannot be sustained.
In December 2008, the Department published its policy on health and well-being for all its staff. One of the aims of the policy is to improve attendance at work.
A new more proactive occupational health service is being tendered now which will also have an impact on attendance at work.
The number of days of sickness absence taken by staff in the core Department in each of the last 12 months are as follows:
Total number of sickness absence days | |
Total estimated cost of absence for period was £2,782,214. In future this information for the core Department will be published on its website at:
The number of days of sick leave taken by staff in the Medicines and Healthcare products Regulatory Agency (MHRA) in each of the last 12 months are presented as follows. Please note that MHRA sickness figures run one month behind so the year to date figures are as follows:
Total number of sickness absence days | |
Next Section | Index | Home Page |